The U.S. Food and Drug Administration (FDA) has authorized the sale of Zyn nicotine pouches, a smokeless alternative aimed at helping adult smokers reduce or quit traditional cigarettes.
This approval highlights a regulatory shift towards harm reduction strategies in tobacco control, emphasizing alternatives that may pose fewer health risks compared to combustible cigarettes.